Ibrutinib combined with TGR-1202 in CLL and mantle cell lymphoma (MCL): preliminary results
What influence do circulating myeloma plasma cells have on the treatment of multiple myeloma?
Dr Moorman's highlights on mixed phenotype acute leukemia (MPAL) from ASH 2016
The potential clinical implications of targeted therapies for DLBCL and why the situation is complex
The unmet need in DLBCL